The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids

Oncogene

Volumn 27, Issue 14, 2008, Pages 2091-2096

  De Witt Hamer, P C ^a   Van Tilborg, A A G ^a   Eijk, P P ^b   Sminia, P ^b   Troost, D ^a   Van Noorden, C J F ^a   Ylstra, B ^b   Leenstra, S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Comparative genomic hybridization; Glioma; Microarray; Primary cell culture; Spheroid

Indexed keywords

ARTICLE; CELL CULTURE; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENETIC STABILITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SPHEROID CELL;

BRAIN NEOPLASMS; CELL CULTURE TECHNIQUES; CHROMOSOME ABERRATIONS; GENOMICS; GLIOBLASTOMA; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 41149163821     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210850     Document Type: Article

References (21)

1. Autio R, Hautaniemi S, Kauraniemi P, Yli-Harja O, Astola J, Wolf M et al. (2003). CGH-Plotter: MATLAB toolbox for CGH-data analysis. Bioinformatics 19: 1714-1715.
2. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau WC, Ledoux P et al. (2005). NCBI GEO: mining millions of expression profiles - database and tools. Nucleic Acids Res 33: D562-D566.
3. Bigner SH, Mark J, Bigner DD. (1987). Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro. Cancer Genet Cytogenet 24: 163-176.
4. Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO. (1990). Multi-cellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475.
5. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P et al. (2002). Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 62: 6205-6210.
6. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al. (1998). Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479.
7. Eisen MB, Spellman PT, Brown PO, Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868.
8. Hartmann C, Kluwe L, Lucke M, Westphal M. (1999). The rate of homozygous CDKN2A/p16 deletions in glioma cell lines and in primary tumors. Int J Oncol 15: 975-982.
9. Izumoto S, Arita N, Ohnishi T, Hiraga S, Taki T, Hayakawa T. (1995). Homozygous deletions of p16INK4A/MTS1 and p15INK4B/MTS2 genes in glioma cells and primary glioma tissues. Cancer Lett 97: 241-247.
10. Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA. (2002). Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet Cytogenet 135: 147-159.
11. Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, Center A et al. (2006). High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 66: 9428-9436.
12. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGFmore closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
13. Loeper S, Romeike BF, Heckmann N, Jung V, Henn W, Feiden W et al. (2001). Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas. Cytogenet Cell Genet 94: 1-8.
14. Pandita A, Aldape KD, Zadeh G, Guha A, James CD. (2004). Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 39: 29-36.
15. Smeets SJ, Braakhuis BJ, Abbas S, Snijders PJ, Ylstra B, van de Wiel MA et al. (2006). Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 25: 2558-2564.
16. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J et al. (2001). Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29: 263-264.
17. Steilen-Gimbel H, Steudel WI, Feiden W, Moringlane JR, Henn W, Zang KD. (1999). Genetic heterogeneity in human astrocytomas: spatial distribution of P16 and TP53 deletions in biopsies. Cancer Genet Cytogenet 113: 115-119.
18. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
19. Sutherland RM. (1988). Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177-184.
20. Voskoglou-Nomikos T, Pater JL, Seymour L. (2003). Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 9: 4227-4239.
21. Wolff JE, Trilling T, Molenkamp G, Egeler RM, Jurgens H. (1999). Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol 125: 481-486.